Germany
Japan
United Kingdom
China
Images
| 1 | CF500038 | Anti-PDX1 mouse monoclonal antibody (TA500038) immunofluorescent staining of HELA cells transiently transfected by pCMV6-ENTRY PDX1 (RC222354). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY PDX1 (RC222354) using anti-PDX1 antibody (TA500038/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA500038 |
| 2 | CF500038 | Anti-PDX1 mouse monoclonal antibody (TA500038) immunofluorescent staining of HELA cells transiently transfected by pCMV6-ENTRY PDX1 (RC222354). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY PDX1 (RC222354) using anti-PDX1 antibody (TA500038/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA500038S |
| 3 | CF500404 | Flow cytometric Analysis of live Jurkat cells, using anti-CD2 antibody (TA500404 at 1:100, Red), compared to IgG1 isotype control (Black). |  | Flow cytometric analysis of living 293T cells transfected with CD2 overexpression plasmid (RC206612, Red)/empty vector (PS100001, Blue) using anti-CD2 antibody (TA500404). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). | TA500404 |
| 4 | CF500404 | Flow cytometric Analysis of live Jurkat cells, using anti-CD2 antibody (TA500404 at 1:100, Red), compared to IgG1 isotype control (Black). | | Flow cytometric analysis of living 293T cells transfected with CD2 overexpression plasmid (RC206612, Red)/empty vector (PS100001, Blue) using anti-CD2 antibody (TA500404). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). | TA500404S |
| 5 | CF500476 | Anti-IRF3 mouse monoclonal antibody (TA500476) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY IRF3 (RC209951). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY IRF3 (RC209951) using anti-IRF3 antibody (TA500476/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500476 |
| 6 | CF500476 | Anti-IRF3 mouse monoclonal antibody (TA500476) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY IRF3 (RC209951). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY IRF3 (RC209951) using anti-IRF3 antibody (TA500476/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500476S |
| 7 | CF500498 | Anti-CTAG1B mouse monoclonal antibody (TA500498) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500498/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500498 |
| 8 | CF500498 | Anti-CTAG1B mouse monoclonal antibody (TA500498) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500498/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500498S |
| 9 | CF500528 | Anti-CTAG1B mouse monoclonal antibody (TA500528) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500528/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500528 |
| 10 | CF500528 | Anti-CTAG1B mouse monoclonal antibody (TA500528) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA500528/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA500528S |
| 11 | CF500542 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC201075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC213858, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1 (1:2000). | TA500542 |
| 12 | CF500542 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC201075, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY STAT1 (RC213858, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-STAT1 (1:2000). | TA500542S |
| 13 | CF500646 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500646 |
| 14 | CF500646 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500646S |
| 15 | CF500649 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500649 |
| 16 | CF500649 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500649S |
| 17 | CF500651 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500651 |
| 18 | CF500651 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500651S |
| 19 | CF500652 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500652 |
| 20 | CF500652 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC205786, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FCGR2A (RC227758, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FCGR2A (1:500). | TA500652S |
| 21 | TA501118 | Flow cytometric analysis of living 293T cells transfected with BTK overexpression plasmid (RC211582), Red)/empty vector (PS100001, Blue) using anti-BTK antibody (TA501118). Cells incubated with a non-specific antibody (Green) were used as isotype control. |  | Flow cytometry analysis of monocytes from non-XLA or XLA patients using anti-BTK antibody (TA501118). Image courtesy: Dr. H. Kanaegane, University of Toyama, Japan. | CF501118 |
| 22 | TA501118S | Flow cytometric analysis of living 293T cells transfected with BTK overexpression plasmid (RC211582), Red)/empty vector (PS100001, Blue) using anti-BTK antibody (TA501118). Cells incubated with a non-specific antibody (Green) were used as isotype control. | | Flow cytometry analysis of monocytes from non-XLA or XLA patients using anti-BTK antibody (TA501118). Image courtesy: Dr. H. Kanaegane, University of Toyama, Japan. | CF501118 |
| 23 | CF501245 | Anti-BIRC5 mouse monoclonal antibody (TA501245) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA501245/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA501245 |
| 24 | CF501245 | Anti-BIRC5 mouse monoclonal antibody (TA501245) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA501245/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA501245S |
| 25 | CF501728 | Anti-SMAD2 mouse monoclonal antibody (TA501728) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501728/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA501728 |
| 26 | CF501728 | Anti-SMAD2 mouse monoclonal antibody (TA501728) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501728/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA501728S |
| 27 | CF501777 | Anti-SMAD2 mouse monoclonal antibody (TA501777) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501777/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA501777 |
| 28 | CF501777 | Anti-SMAD2 mouse monoclonal antibody (TA501777) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY SMAD2 (RC204604). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SMAD2 (RC204604) using anti-SMAD2 antibody (TA501777/green, left). 293T cells transfected with empty vector served as a negative control (right) (1:100). | TA501777S |
| 29 | CF501778 | Anti-DCX mouse monoclonal antibody (TA501778) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY DCX (RC221891). |  | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY DCX (RC221891) using anti-DCX mouse monoclonal antibody (TA501778, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100). | TA501778 |
| 30 | CF501778 | Anti-DCX mouse monoclonal antibody (TA501778) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY DCX (RC221891). | | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY DCX (RC221891) using anti-DCX mouse monoclonal antibody (TA501778, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100). | TA501778S |
| 31 | CF502106 | Anti-CALCOCO2 mouse monoclonal antibody (TA502106) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502106/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502106 |
| 32 | CF502106 | Anti-CALCOCO2 mouse monoclonal antibody (TA502106) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502106/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502106S |
| 33 | CF502153 | Anti-CALCOCO2 mouse monoclonal antibody (TA502153) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502153/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502153 |
| 34 | CF502153 | Anti-CALCOCO2 mouse monoclonal antibody (TA502153) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CALCOCO2 (RC203843). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CALCOCO2 (RC203843) using anti-CALCOCO2 antibody (TA502153/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502153S |
| 35 | TA502234 | Flow cytometric analysis of living 293T cells transfected with BIRC5 overexpression plasmid (RC205935), Red)/empty vector (PS100001, Blue) using anti-BIRC5 antibody (TA502234). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). |  | HEK293T cells transfected with either RC205935 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-BIRC5 antibody (TA502234), and then analyzed by flow cytometry. | CF502234 |
| 36 | TA502234S | Flow cytometric analysis of living 293T cells transfected with BIRC5 overexpression plasmid (RC205935), Red)/empty vector (PS100001, Blue) using anti-BIRC5 antibody (TA502234). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). | | HEK293T cells transfected with either RC205935 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-BIRC5 antibody (TA502234), and then analyzed by flow cytometry. | CF502234 |
| 37 | CF502236 | Anti-BIRC5 mouse monoclonal antibody (TA502236) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA502236/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502236 |
| 38 | CF502236 | Anti-BIRC5 mouse monoclonal antibody (TA502236) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY BIRC5 (RC205935). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY BIRC5 (RC205935) using anti-BIRC5 antibody (TA502236/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA502236S |
| 39 | TA502832 | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502832, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). |  | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502832). | CF502832 |
| 40 | TA502832S | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502832, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). | | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502832). | CF502832 |
| 41 | TA502935 | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502935, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). |  | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502935). | CF502935 |
| 42 | TA502935S | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502935, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). | | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502935). | CF502935 |
| 43 | TA502943 | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502943, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). |  | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502943). | CF502943 |
| 44 | TA502943S | Immunofluorescent staining of Hela cells using anti-CDK2 mouse monoclonal antibody (TA502943, green, upper left; merged, upper right) or Isotype control (merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). | | Immunofluorescent staining of HeLa cells using anti-CDK2 mouse monoclonal antibody (TA502943). | CF502943 |
| 45 | CF503933 | HEK293T cells transfected with either RC207170 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CDH2 antibody (TA503933), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC207170 plasmid (red) or empty vector (blue) were immunostained by anti-CDH2 antibody (TA503933) or isotype control antibody (green), and then analyzed by flow cytometry (1:50). | TA503933 |
| 46 | CF503933 | HEK293T cells transfected with either RC207170 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CDH2 antibody (TA503933), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC207170 plasmid (red) or empty vector (blue) were immunostained by anti-CDH2 antibody (TA503933) or isotype control antibody (green), and then analyzed by flow cytometry (1:50). | TA503933S |
| 47 | TA504507 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223061, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME. | CF504507 |
| 48 | TA504507S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223013, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MME (RC223061, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MME. | CF504507 |
| 49 | CF504762 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504762), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504762) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504762 |
| 50 | CF504762 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504762), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504762) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504762S |
| 51 | CF504763 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504763), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504763) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504763 |
| 52 | CF504763 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504763), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504763) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504763S |
| 53 | CF504773 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504773), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504773) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504773 |
| 54 | CF504773 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504773), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504773) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504773S |
| 55 | CF504773 | Anti-PECAM1 mouse monoclonal antibody (TA504773) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654). |  | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654) using anti-PECAM1 mouse monoclonal antibody (TA504773, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100). | TA504773 |
| 56 | CF504773 | Anti-PECAM1 mouse monoclonal antibody (TA504773) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654). | | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY PECAM1 (RC208654) using anti-PECAM1 mouse monoclonal antibody (TA504773, green, upper left; merged, upper right). Cell nuclei were stained with DAPI (blue, lower left). 293T cells transfected with empty vector plasmid served as negative control ( merged, lower right) (1:100). | TA504773S |
| 57 | CF504803 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504803), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504803) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504803 |
| 58 | CF504803 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504803), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504803) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504803S |
| 59 | CF504804 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504804), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504804) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504804 |
| 60 | CF504804 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504804), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504804) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504804S |
| 61 | CF504812 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504812), and then analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504812) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504812 |
| 62 | CF504812 | HEK293T cells transfected with either RC208654 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PECAM1 antibody (TA504812), and then analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC208654 plasmid (red) or empty vector (blue) were immunostained by anti-PECAM1 antibody (TA504812) or isotype control antibody (green), and then analyzed by flow cytometry (1:100). | TA504812S |
| 63 | TA505700 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-G (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. Positive lysates LY400968 (100ug) and LC400968 (20ug) can be purchased separately from OriGene. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MAPK3 (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. | CF505700 |
| 64 | TA505700S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY HLA-G (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. Positive lysates LY400968 (100ug) and LC400968 (20ug) can be purchased separately from OriGene. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MAPK3 (RC204196, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MAPK3. | CF505700 |
| 65 | CF505945 | Anti-CTAG1B mouse monoclonal antibody (TA505945) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505945/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505945 |
| 66 | CF505945 | Anti-CTAG1B mouse monoclonal antibody (TA505945) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505945/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505945S |
| 67 | CF505946 | Anti-CTAG1B mouse monoclonal antibody (TA505946) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505946/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505946 |
| 68 | CF505946 | Anti-CTAG1B mouse monoclonal antibody (TA505946) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505946/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505946S |
| 69 | CF505948 | Anti-CTAG1B mouse monoclonal antibody (TA505948) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505948/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505948 |
| 70 | CF505948 | Anti-CTAG1B mouse monoclonal antibody (TA505948) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505948/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505948S |
| 71 | CF505951 | Anti-CTAG1B mouse monoclonal antibody (TA505951) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505951/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505951 |
| 72 | CF505951 | Anti-CTAG1B mouse monoclonal antibody (TA505951) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505951/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505951S |
| 73 | CF505952 | Anti-CTAG1B mouse monoclonal antibody (TA505952) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505952/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505952 |
| 74 | CF505952 | Anti-CTAG1B mouse monoclonal antibody (TA505952) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505952/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505952S |
| 75 | CF505955 | Anti-CTAG1B mouse monoclonal antibody (TA505955) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505955/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505955 |
| 76 | CF505955 | Anti-CTAG1B mouse monoclonal antibody (TA505955) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505955/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505955S |
| 77 | CF505956 | Anti-CTAG1B mouse monoclonal antibody (TA505956) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505956/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505956 |
| 78 | CF505956 | Anti-CTAG1B mouse monoclonal antibody (TA505956) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505956/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505956S |
| 79 | CF505959 | Anti-CTAG1B mouse monoclonal antibody (TA505959) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505959/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505959 |
| 80 | CF505959 | Anti-CTAG1B mouse monoclonal antibody (TA505959) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505959/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505959S |
| 81 | CF505965 | Anti-CTAG1B mouse monoclonal antibody (TA505965) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505965/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505965 |
| 82 | CF505965 | Anti-CTAG1B mouse monoclonal antibody (TA505965) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505965/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505965S |
| 83 | CF505970 | Anti-CTAG1B mouse monoclonal antibody (TA505970) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505970/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505970 |
| 84 | CF505970 | Anti-CTAG1B mouse monoclonal antibody (TA505970) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505970/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505970S |
| 85 | CF505971 | Anti-CTAG1B mouse monoclonal antibody (TA505971) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505971/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505971 |
| 86 | CF505971 | Anti-CTAG1B mouse monoclonal antibody (TA505971) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505971/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505971S |
| 87 | CF505972 | Anti-CTAG1B mouse monoclonal antibody (TA505972) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505972/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505972 |
| 88 | CF505972 | Anti-CTAG1B mouse monoclonal antibody (TA505972) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505972/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505972S |
| 89 | CF505974 | Anti-CTAG1B mouse monoclonal antibody (TA505974) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505974/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505974 |
| 90 | CF505974 | Anti-CTAG1B mouse monoclonal antibody (TA505974) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CTAG1B (RC213318). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CTAG1B (RC213318) using anti-CTAG1B antibody (TA505974/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA505974S |
| 91 | CF506331 | Anti-FCGR1A mouse monoclonal antibody (TA506331) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FCGR1A (RC207487). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY FCGR1A (RC207487) using anti-FCGR1A antibody (TA506331/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA506331 |
| 92 | CF506331 | Anti-FCGR1A mouse monoclonal antibody (TA506331) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY FCGR1A (RC207487). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY FCGR1A (RC207487) using anti-FCGR1A antibody (TA506331/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA506331S |
| 93 | CF506350 | Anti-CD33 mouse monoclonal antibody (TA506350) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD33 (RC207023). |  | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CD33 (RC207023) using anti-CD33 antibody (TA506350/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA506350 |
| 94 | CF506350 | Anti-CD33 mouse monoclonal antibody (TA506350) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD33 (RC207023). | | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY CD33 (RC207023) using anti-CD33 antibody (TA506350/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | TA506350S |
| 95 | CF506392 | Anti-CD163 mouse monoclonal antibody (TA506392) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD163 (RC208557). |  | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY CD163 (RC208557}) using anti-CD163 mouse monoclonal antibody (TA506392, green, upper left; merged, upper right) or empty vector control plasmid ( merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). | TA506392 |
| 96 | CF506392 | Anti-CD163 mouse monoclonal antibody (TA506392) immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY CD163 (RC208557). | | Immunofluorescent staining of 293T cells transiently transfected by pCMV6-ENTRY CD163 (RC208557}) using anti-CD163 mouse monoclonal antibody (TA506392, green, upper left; merged, upper right) or empty vector control plasmid ( merged, lower right). Cell nuclei were stained with DAPI (blue, lower left) (1:100). | TA506392S |
| 97 | CF507240 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507240 |
| 98 | CF507240 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507240S |
| 99 | CF507243 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507243 |
| 100 | CF507243 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507243S |
| 101 | CF507244 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507244 |
| 102 | CF507244 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507244S |
| 103 | CF507245 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507245 |
| 104 | CF507245 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC200299, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SMAD1 (RC223918, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SMAD1 (1:500). | TA507245S |
| 105 | TA801872 | E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16. | CF801872 |
| 106 | TA801872S | E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16. | CF801872 |
| 107 | TA801881 | E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16. | CF801881 |
| 108 | TA801881S | E.coli lysate (left lane) and E.coli lysate expressing Human recombinant protein fragment (right lane) corresponding to amino acids 10329-10628 of human MUC16 (NP_078966) were separated by SDS-PAGE and immunoblotted with anti-MUC16 monoclonal antibody (1:1000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MUC16 (SC200446, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MUC16. | CF801881 |
| 109 | TA801940 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801940), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801940), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801940 |
| 110 | TA801940S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801940), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801940), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801940 |
| 111 | CF801941 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then analyzed by flow cytometry (1:100). | TA801941 |
| 112 | CF801941 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA801941), and then analyzed by flow cytometry (1:100). | TA801941S |
| 113 | TA801941 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801941), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801941), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801941 |
| 114 | TA801941S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801941), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801941), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801941 |
| 115 | TA801972 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801972), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801972), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801972 |
| 116 | TA801972S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA801972), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA801972), (Red), compared to a nonspecific negative control antibody, (Blue). | CF801972 |
| 117 | TA802083 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802083), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802083), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802083 |
| 118 | TA802083S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802083), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802083), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802083 |
| 119 | CF802218 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC201301, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC231040, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3 (1:500). | TA802218 |
| 120 | CF802218 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC201301, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY DDIT3 (RC231040, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-DDIT3 (1:500). | TA802218S |
| 121 | CF802402 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then analyzed by flow cytometry (1:100). | TA802402 |
| 122 | CF802402 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802402), and then analyzed by flow cytometry (1:100). | TA802402S |
| 123 | TA802402 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802402), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802402), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802402 |
| 124 | TA802402S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802402), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802402), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802402 |
| 125 | TA802403 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802403), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802403), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802403 |
| 126 | TA802403S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802403), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802403), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802403 |
| 127 | CF802404 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then analyzed by flow cytometry (1:100). | TA802404 |
| 128 | CF802404 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802404), and then analyzed by flow cytometry (1:100). | TA802404S |
| 129 | TA802404 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802404), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802404), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802404 |
| 130 | TA802404S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802404), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802404), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802404 |
| 131 | CF802406 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then analyzed by flow cytometry (1:100). | TA802406 |
| 132 | CF802406 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802406), and then analyzed by flow cytometry (1:100). | TA802406S |
| 133 | TA802406 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802406), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802406), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802406 |
| 134 | TA802406S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802406), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802406), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802406 |
| 135 | TA802408 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802408), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802408), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802408 |
| 136 | TA802408S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802408), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802408), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802408 |
| 137 | CF802409 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then analyzed by flow cytometry (1:100). | TA802409 |
| 138 | CF802409 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802409), and then analyzed by flow cytometry (1:100). | TA802409S |
| 139 | TA802409 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802409), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802409), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802409 |
| 140 | TA802409S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802409), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802409), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802409 |
| 141 | CF802410 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then analyzed by flow cytometry (1:100). | TA802410 |
| 142 | CF802410 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802410), and then analyzed by flow cytometry (1:100). | TA802410S |
| 143 | TA802410 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802410), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802410), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802410 |
| 144 | TA802410S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802410), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802410), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802410 |
| 145 | TA802411 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802411), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802411), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802411 |
| 146 | TA802411S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802411), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802411), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802411 |
| 147 | CF802415 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then analyzed by flow cytometry (1:100). | TA802415 |
| 148 | CF802415 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802415), and then analyzed by flow cytometry (1:100). | TA802415S |
| 149 | TA802415 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802415), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802415), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802415 |
| 150 | TA802415S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802415), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802415), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802415 |
| 151 | CF802417 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then analyzed by flow cytometry (1:100). | TA802417 |
| 152 | CF802417 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802417), and then analyzed by flow cytometry (1:100). | TA802417S |
| 153 | TA802417 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802417), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802417), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802417 |
| 154 | TA802417S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802417), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802417), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802417 |
| 155 | TA802418 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802418), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802418), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802418 |
| 156 | TA802418S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802418), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802418), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802418 |
| 157 | CF802422 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then analyzed by flow cytometry (1:100). | TA802422 |
| 158 | CF802422 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802422), and then analyzed by flow cytometry (1:100). | TA802422S |
| 159 | TA802423 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802423), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802423), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802423 |
| 160 | TA802423S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802423), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802423), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802423 |
| 161 | CF802424 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then analyzed by flow cytometry (1:100). | TA802424 |
| 162 | CF802424 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802424), and then analyzed by flow cytometry (1:100). | TA802424S |
| 163 | TA802424 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802424), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802424), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802424 |
| 164 | TA802424S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802424), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802424), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802424 |
| 165 | TA802425 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802425), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802425), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802425 |
| 166 | TA802425S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802425), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802425), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802425 |
| 167 | CF802427 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then analyzed by flow cytometry (1:100). | TA802427 |
| 168 | CF802427 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802427), and then analyzed by flow cytometry (1:100). | TA802427S |
| 169 | TA802427 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802427), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802427), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802427 |
| 170 | TA802427S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802427), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802427), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802427 |
| 171 | CF802428 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then analyzed by flow cytometry (1:100). | TA802428 |
| 172 | CF802428 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802428), and then analyzed by flow cytometry (1:100). | TA802428S |
| 173 | TA802428 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802428), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802428), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802428 |
| 174 | TA802428S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802428), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802428), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802428 |
| 175 | CF802439 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then analyzed by flow cytometry (1:100). | TA802439 |
| 176 | CF802439 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802439), and then analyzed by flow cytometry (1:100). | TA802439S |
| 177 | TA802439 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802439), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802439), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802439 |
| 178 | TA802439S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802439), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802439), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802439 |
| 179 | CF802440 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then living cells were analyzed by flow cytometry. |  | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then analyzed by flow cytometry (1:100). | TA802440 |
| 180 | CF802440 | HEK293T cells transfected with either RC206494 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then living cells were analyzed by flow cytometry. | | Living HEK293T cells transfected with either RC206494 overexpress plasmid (Red), compared to an IgG isotype control, (Green) or empty vector control plasmid (Blue) were immunostained by anti-CD5 antibody (TA802440), and then analyzed by flow cytometry (1:100). | TA802440S |
| 181 | TA802440 | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802440), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). |  | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802440), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802440 |
| 182 | TA802440S | Flow cytometric analysis of living 50ng/ml IL2-stimulated Jurkat cells, using anti-CD5 antibody (TA802440), (red), compared to an IgG isotype control, (green), and negative control (PBS), (blue) (1:100). | | Flow cytometric Analysis of living Jurkat cells, using anti-CD5 antibody (TA802440), (Red), compared to a nonspecific negative control antibody, (Blue). | CF802440 |
| 183 | TA802443 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. |  | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802443 |
| 184 | TA802443S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. | | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802443 |
| 185 | TA802572 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. |  | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802572 |
| 186 | TA802572S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. | | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802572 |
| 187 | TA802588 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. |  | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802588 |
| 188 | TA802588S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KDR (RC219851, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KDR. (1:50. Positive lysates LY400826 (100ug) and LC400826 (20ug) can be purchased separately from OriGene. | | HEK293T lysate (5ug, left lane) and HEK293T cell lysate expressing human recombinant protein fragment corresponding to amino acids 786-1356 of human KDR (NP_002244). | CF802588 |
| 189 | TA803259 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). |  | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803259 |
| 190 | TA803259S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). | | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803259 |
| 191 | TA803275 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). |  | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803275 |
| 192 | TA803275S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). | | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803275 |
| 193 | TA803310 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). |  | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803310 |
| 194 | TA803310S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY VWF (RC218497, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-VWF (1:500). | | SF9 cells lysate (5 ug, left lane) and SF9 cells lysate expressing human recombinant protein fragment (5 ug, right lane) corresponding to amino acids 764-1263 of human VWF (NP_000543) were separated by SDS-PAGE and immunoblotted with anti-VWF | CF803310 |
| 195 | TA804902 | Western blot analysis of extracts (35ug) from different cell line by using anti-CTNND1 monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from HepG2 cell line by using anti-ASL monoclonal antibody (1:500). | CF804902 |
| 196 | TA804902S | Western blot analysis of extracts (35ug) from different cell line by using anti-CTNND1 monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from HepG2 cell line by using anti-ASL monoclonal antibody (1:500). | CF804902 |
| 197 | TA804937 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220449, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4 (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220500, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4. | CF804937 |
| 198 | TA804937S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220449, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4 (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ERBB4 (RC220500, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ERBB4. | CF804937 |
| 199 | CF805640 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | TA805640 |
| 200 | CF805640 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | TA805640S |
| 201 | TA805648 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` |  | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805648 |
| 202 | TA805648S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805648 |
| 203 | TA805653 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` |  | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805653 |
| 204 | TA805653S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805653 |
| 205 | TA805656 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` |  | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805656 |
| 206 | TA805656S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805656 |
| 207 | TA805657 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` |  | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805657 |
| 208 | TA805657S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805657 |
| 209 | TA805671 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` |  | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805671 |
| 210 | TA805671S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RB1 (RC206933, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-RB1 mouse monoclonal antibody.1:500` | | Human recombinant protein fragment corresponding to amino acids 309-590 of human RB1 (NP_000312) produced in E.coli. | CF805671 |
| 211 | TA806188 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500). |  | Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli. | CF806188 |
| 212 | TA806188S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500). | | Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli. | CF806188 |
| 213 | TA806197 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500). |  | Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli. | CF806197 |
| 214 | TA806197S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NR3C1 (RC220189, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NR3C1 (1:500). | | Human recombinant protein fragment corresponding to amino acids 1-265 of human NR3C1 (NP_000167) produced in E.coli. | CF806197 |
| 215 | CF806586 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDCD1LG2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDCD1LG2. |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDL2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDL2 (1:1k) | TA806586 |
| 216 | CF806586 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDCD1LG2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDCD1LG2. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDL2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDL2 (1:1k) | TA806586S |
| 217 | CF806803 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:500). | TA806803 |
| 218 | CF806803 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CTGF (RC210336, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CTGF (1:500). | TA806803S |
| 219 | CF806846 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500). | TA806846 |
| 220 | CF806846 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500). | TA806846S |
| 221 | CF806847 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500). | TA806847 |
| 222 | CF806847 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY MMP2 (RC200720, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-MMP2 (1:500). | TA806847S |
| 223 | TA807180 | Flow cytometric analysis of living 293T cells transfected with LAG3 overexpression plasmid (RC220269), Red)/empty vector (PS100001, Blue) using anti-LAG3 antibody (TA807180). Cells incubated with a non-specific antibody (Green) were used as isotype control. (1;100) |  | HEK293T cells transfected with either empty vector control plasmid (A), RC220269 overexpress plasmid (B) were immunostained by anti-LAG3 antibody (Origene, TA807180, Red), compared to an IgG isotype control (Origene, TA180144, blue) or PBS (black)then analyzed by flow cytometry. (1:100). | CF807180 |
| 224 | TA807180S | Flow cytometric analysis of living 293T cells transfected with LAG3 overexpression plasmid (RC220269), Red)/empty vector (PS100001, Blue) using anti-LAG3 antibody (TA807180). Cells incubated with a non-specific antibody (Green) were used as isotype control. (1;100) | | HEK293T cells transfected with either empty vector control plasmid (A), RC220269 overexpress plasmid (B) were immunostained by anti-LAG3 antibody (Origene, TA807180, Red), compared to an IgG isotype control (Origene, TA180144, blue) or PBS (black)then analyzed by flow cytometry. (1:100). | CF807180 |
| 225 | CF807239 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:500). | TA807239 |
| 226 | CF807239 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ESR1 (RC213277, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-ESR1 (1:500). | TA807239S |
| 227 | CF807341 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500). | TA807341 |
| 228 | CF807341 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500). | TA807341S |
| 229 | CF807531 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500). | TA807531 |
| 230 | CF807531 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDX1 (RC222354, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDX1 (1:500). | TA807531S |
| 231 | CF808748 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808748) (1:50) |  | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808748) (1:50) | TA808748 |
| 232 | CF808748 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808748) (1:50) | | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808748) (1:50) | TA808748S |
| 233 | CF808749 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808749) (1:50) |  | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808749) (1:50) | TA808749 |
| 234 | CF808749 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808749) (1:50) | | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808749) (1:50) | TA808749S |
| 235 | CF808752 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808752) (1:50) |  | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808752) (SUPERTN) (1:50) | TA808752 |
| 236 | CF808752 | Flow cytometric Analysis of living HEK293 cells transfected with human LGR4, LGR5, LGR6 v1 and v2, mouse LGR4, LGR5 or LGR6 using anti-LGR5 antibody (TA808752) (1:50) | | Flow cytometric Analysis of stable transfection cell line LGR5 (RC212825) (Red) compared to negative control HEK293T cell line (blue)using anti-LGR5 antibody (TA808752) (SUPERTN) (1:50) | TA808752S |
| 237 | TA809097 | Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200). | CF809097 |
| 238 | TA809097S | Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200). | CF809097 |
| 239 | TA809143 | Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200). | CF809143 |
| 240 | TA809143S | Western blot analysis of extracts (35ug) from 2 different cell by using anti-GATA3 monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from 3 different cell lines by using anti-GATA3 monoclonal antibody (1:200). | CF809143 |
| 241 | TA809316 | Western blot analysis of extracts (35ug) from 5 different cell lines and human plasma by using anti-IRF3 monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from 6 different cell lines by using anti-IRF3 monoclonal antibody (1:500). | CF809316 |
| 242 | TA809316S | Western blot analysis of extracts (35ug) from 5 different cell lines and human plasma by using anti-IRF3 monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from 6 different cell lines by using anti-IRF3 monoclonal antibody (1:500). | CF809316 |
| 243 | TA809425 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC209951, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC231144, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:2000). | CF809425 |
| 244 | TA809425S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC209951, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IRF3 (RC231144, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IRF3 (1:2000). | CF809425 |
| 245 | TA809449 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809449 |
| 246 | TA809449S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809449 |
| 247 | TA809456 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809456 |
| 248 | TA809456S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809456 |
| 249 | TA809457 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809457 |
| 250 | TA809457S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC202894, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:500). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FOXO3 (RC209846, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FOXO3 (1:2000). | CF809457 |
| 251 | CF809460 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:500). | TA809460 |
| 252 | CF809460 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDK15 (RC219623, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDK15 (1:500). | TA809460S |
| 253 | TA809831 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000). | CF809831 |
| 254 | TA809831S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000). | CF809831 |
| 255 | TA809834 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000). | CF809834 |
| 256 | TA809834S | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:1000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SIRT1 (RC218134, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-SIRT1 (1:2000). | CF809834 |
| 257 | TA810027 | Western blot analysis of extracts (35ug) from 17 different cell lines by using anti-POLR2A monoclonal antibody. 1:500` |  | Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500). | CF810027 |
| 258 | TA810027S | Western blot analysis of extracts (35ug) from 17 different cell lines by using anti-POLR2A monoclonal antibody. 1:500` | | Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500). | CF810027 |
| 259 | TA810050 | Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-POLR2A monoclonal antibody. 1:500` |  | Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500). | CF810050 |
| 260 | TA810050S | Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-POLR2A monoclonal antibody. 1:500` | | Western blot analysis of extracts (35ug) from 7 different cell lines by using anti-POLR2A monoclonal antibody (1:500). | CF810050 |
| 261 | TA810605 | Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500). | CF810605 |
| 262 | TA810605S | Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500). | CF810605 |
| 263 | TA810614 | Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500). | CF810614 |
| 264 | TA810614S | Western blot analysis of extracts (35ug) from 2 cell lines and 2 tissues lysates by using anti-MME monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from RAMOS cell line by using anti-MME monoclonal antibody (1:500). | CF810614 |
| 265 | CF810942 | Western blot analysis of extracts (35ug) from 2 different cell lines by using anti-HOXD8 monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from A375 cell by using anti-HOXD8 monoclonal antibody (1:500). | TA810942 |
| 266 | CF810942 | Western blot analysis of extracts (35ug) from 2 different cell lines by using anti-HOXD8 monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from A375 cell by using anti-HOXD8 monoclonal antibody (1:500). | TA810942S |
| 267 | TA810988 | Western blot analysis of extracts (35ug) from 5 cell lines lysates by using anti-ASH2L monoclonal antibody (1:500). |  | Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-ASH2L monoclonal antibody (1:500). | CF810988 |
| 268 | TA810988S | Western blot analysis of extracts (35ug) from 5 cell lines lysates by using anti-ASH2L monoclonal antibody (1:500). | | Western blot analysis of extracts (35ug) from 5 different cell lines by using anti-ASH2L monoclonal antibody (1:500). | CF810988 |
| 269 | CF811879 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:2000). |  | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:500). | TA811879 |
| 270 | CF811879 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:2000). | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY KLF5 (RC202438, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-KLF5 (1:500). | TA811879S |
| 271 | CF813014 | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, red), compared to an IgG isotype control (blue) (1:100). |  | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, Tecentriq, red), compared to an IgG isotype control (blue) (1:100). | TA813014S |
| 272 | TA813014 | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, red), compared to an IgG isotype control (blue) (1:100). | | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813014, Tecentriq, red), compared to an IgG isotype control (blue) (1:100). | TA813014S |
| 273 | CF813014 | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Red) compared to an IgG isotype control antibody (Blue) (1:100). |  | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Tecentriq) (Red) compared to an IgG isotype control antibody (Blue) (1:100). | TA813014S |
| 274 | TA813014 | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Red) compared to an IgG isotype control antibody (Blue) (1:100). | | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813014, Tecentriq) (Red) compared to an IgG isotype control antibody (Blue) (1:100). | TA813014S |
| 275 | TA813015S | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, Avelumab, red), compared to an IgG isotype control (blue) (1:100). |  | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, red), compared to an IgG isotype control (blue) (1:100). | CF813015 |
| 276 | TA813015S | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, Avelumab, red), compared to an IgG isotype control (blue) (1:100). | | Flow cytometric Analysis of living HCC78 cells, using anti-PDL1 antibody (TA813015, red), compared to an IgG isotype control (blue) (1:100). | TA813015 |
| 277 | TA813015S | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Avelumab) (Red) compared to an IgG isotype control antibody (Blue) (1:100). |  | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Red) compared to an IgG isotype control antibody (Blue) (1:100). | CF813015 |
| 278 | TA813015S | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Avelumab) (Red) compared to an IgG isotype control antibody (Blue) (1:100). | | Flow cytometric analysis of living PDL1/CD274 stable expression cells using anti-CD274 antibody (TA813015, Red) compared to an IgG isotype control antibody (Blue) (1:100). | TA813015 |
| 279 | TA324829 | Fluorescent confocal image of Hela cell stained with MEF2C Antibody (S387).Hela cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.1%, 10 min), then incubated with MEF2C primary antibody (1:25, 1 h at 37°C). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400, 50 min at 37°C).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7units/ml, 1 h at 37°C). Nuclei were counterstained with DAPI (blue) (10 ug/ml, 10 min).MEF2C immunoreactivity is localized to vesicles and Nucleus significantly. |  | IF image of Hela cell stained with MEF2C Antibody (S387) (Cat#TA302220).Hela cells were incubated with MEF2C primary antibody (1:25, 1 h at 37°C). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7 units/ml). Nuclei were counterstained with DAPI (blue).MEF2C immunoreactivity is localized to vesicles and Nucleus significantly. | TA302220 |
| 280 | TA302220 | Formalin-fixed and paraffin-embedded human brain tissue reacted with MEF2C Antibody (S387) (Cat.#TA302220), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |  | Formalin-fixed and paraffin-embedded human brain tissue reacted with MEF2C Antibody (S387), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. | TA324829 |
| 281 | TA302220 | MEF2C Antibody (pS387) (Cat. #TA302220) western blot analysis in HL-60, K562 cell line lysates (35ug/lane).This demonstrates the MEF2C antibody detected the MEF2C protein (arrow). |  | MEF2C Antibody (pS387) western blot analysis in HL-60, K562 cell line lysates (35ug/lane).This demonstrates the MEF2C antibody detected the MEF2C protein (arrow). | TA324829 |
| 282 | TA354995 | Immunofluorescence of NALP3 in K562 cells with NALP3 antibody at 20ug/ml. |  | Immunofluorescence of NALP3 in K562 cells with NALP3 antibody at 5ug/ml. | TA306860 |
| 283 | TA160032 | Hemagglutinin antibody at 2 ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein. |  | Hemagglutinin antibody at 2ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein. | TA160209 |
| 284 | TA160033 | Hemagglutinin antibody at 2 ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein. |  | Hemagglutinin antibody at 2ug/mL specifically recognizes Avian H5N1 influenza virus but not seasonal influenza virus A H1N1 Hemagglutinin protein. | TA160210 |
| 285 | TA160034 | Western blot analysis of (A) 5 ng and (B) 25 ng of recombinant HA1 with Hemagglutinin antibody at 1 ug/mL. |  | Western blot analysis of (A) 5 ng and (B) 25 ng of recombinant HA1 with Hemagglutinin antibody at 1ug/mL. | TA160211 |
| 286 | TA160216 | Seasonal Influenza A Hemagglutinin antibody (2ug/mL) recognizes seasonal influenza A (H1N1), but not swine-origin influenza A (S-OIV, H1N1), Hemagglutinin protein in ELISA. |  | Seasonal Influenza A Hemagglutinin antibody recognizes seasonal influenza A (H1N1), but not swine-origin influenza A (S-OIV, H1N1), Hemagglutinin protein in ELISA. | TA160039 |
| 287 | TA160044 | Western blot analysis of 20 ng of (A) viral p24 and (B) recombinant p24 with anti-HIV-1 p24 antibody at (A) 0.5 ug/mL and (B) 0.2 ug/mL, respectively. |  | Western blot analysis of 20 ng of (A) viral p24 and (B) recombinant p24 with anti-HIV-1 p24 antibody PM-6335 at (A) 0.5 ug/mL and (B) 0.2 ug/mL, respectively. | TA160221 |
| 288 | TA160126 | Adenosine-3', 5'-cyclic AMP immorbolized onto plates, followed by addition of stand cyclic AMP. The mouse anti c-AMP was added subsequentially, and visiualized by chromatogenic substrate. Each sample was triplicate. IC50 was then calculated. |  | ELISA: Adenosine-3', 5'-cyclic AMP immorbolized onto plates, followed by addition of stand cyclic AMP. The mouse anti-c-AMP antibody was added subsequentially, and visiualized by chromatogenic substrate. Each sample was triplicate. IC50 was then calculated. | TA354437 |
| 289 | TA100033 | HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution. |  | HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution. | TA100032 |
| 290 | TA100033 | HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000). | TA180011 |
| 291 | TA100032 | HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000). | TA180011 |
| 292 | TA100034 | HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution. | | HEK293T cells were transfected with the pCMV6-AC-IT5-RFP (PS100098 with RFP to express RFP-IT5 fusion protein, Left laneLeft lane) or pCMV6-AN-IT5-RFP (PS100095 with RFP to express IT5-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT5 antibody (TA100033) at 1:1000 dilution. | TA100033 |
| 293 | TA100034 | HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution. | | HEK293T cells were transfected with the pCMV6-AC-IT6-RFP (PS100099 with RFP to express RFP-IT6 fusion protein, Left lane) or pCMV6-AN-IT6-RFP (PS100096 with RFP to express IT6-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT6 antibody (TA100032) at 1:1000 dilution. | TA100032 |
| 294 | TA100034 | HEK293T cells were transfected with the pCMV6-AC-IT10-RFP (PS100100 with RFP to express RFP-IT10 fusion protein, Left lane) or pCMV6-AN-IT10-RFP (PS100097 with RFP to express IT10-RFP fusion protein, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (10 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-IT10 antibody (TA100034) at 1:1000 dilution. | | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AcGFP1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-AcGFP1/PS-CFP2 (TA180011, 1:2000). | TA180011 |
| 295 | UM500012 | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500012/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). |  | Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500012, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner. | UM500012CF |
| 296 | UM500012 | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500012/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | | Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500012, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner. | UM570012 |
| 297 | UM500013 | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500013/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). |  | Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500013, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner. | UM500013CF |
| 298 | UM500013 | Immunofluorescent staining of 293T cells transfected by pCMV6-ENTRY SQSTM1 (RC203214) using anti-SQSTM1 antibody (UM500013/green, upper left; DAPI/blue, lower left; MERGED, upper right). 293T cells transfected with empty vector served as a negative control (MERGED, lower right) (1:100). | | Immunofluorescent staining of A549 cells using SQSTM1 mouse monoclonal antibody (UM500013, green). Actin filaments were labeled with TRITC-phalloidin (red), and nuclear with DAPI (blue). The three-color overlay image is located at the bottom-right corner. | UM570013 |
| 299 | UM500023 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDH2 (RC207170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDH2 mouse monoclonal antibody (1:1000). |  | Western Blot analysis of extracts (35ug) from 11 different cell lines by using anti-CDH2 monoclonal antibody (Clone UMAB23) | UM570023 |
| 300 | UM500023 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDH2 (RC207170, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CDH2 mouse monoclonal antibody (1:1000). | | Western Blot analysis of extracts (35ug) from 11 different cell lines by using anti-CDH2 monoclonal antibody (Clone UMAB23) | UM500023CF |
| 301 | UM500031 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PECAM1 (RC208654, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PECAM1 mouse monoclonal antibody.1:500` |  | Western Blot analysis of MOLT-4 cell lysate (35ug) by using anti-PECAM1 monoclonal antibody (Clone UMAB31) | UM500031CF |
| 302 | UM500031 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PECAM1 (RC208654, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PECAM1 mouse monoclonal antibody.1:500` | | Western Blot analysis of MOLT-4 cell lysate (35ug) by using anti-PECAM1 monoclonal antibody (Clone UMAB31) | UM570031 |
| 303 | UM500098 | Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). |  | Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM570098 |
| 304 | UM500098 | Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). | | Western blot analysis of U251 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM500098CF |
| 305 | UM500098 | Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). |  | Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM500098CF |
| 306 | UM500098 | Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). | | Western blot analysis of SF295 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM570098 |
| 307 | UM500098 | Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). |  | Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM570098 |
| 308 | UM500098 | Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody (1:4000). | | Western blot analysis of MDA-MB231 cell lysate (35ug) by using anti-CD44 monoclonal antibody. | UM500098CF |
| 309 | UM500099 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD44 (RC221771, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates were separated by SDS-PAGE and immunoblotted with anti-CD44 (1:500). |  | Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD44 monoclonal antibody (Clone UMAB134) | UM570099 |
| 310 | UM500099 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD44 (RC221771, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates were separated by SDS-PAGE and immunoblotted with anti-CD44 (1:500). | | Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD44 monoclonal antibody (Clone UMAB134) | UM500099CF |
| 311 | UM800008 | OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57 ) very specifically recognizes MUC1 antigen on OriGene protein microarray chip (1:100). |  | OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57) very specifically recognizes MUC1 antigen on OriGene protein microarray chip. | UM870008 |
| 312 | UM800008 | OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57 ) very specifically recognizes MUC1 antigen on OriGene protein microarray chip (1:100). | | OriGene overexpression protein microarray chip was immunostained with UltraMAB anti-MUC1 mouse monoclonal antibody (Clone UMAB37). The positive reactive proteins are highlighted with two red arrows in the enlarged subarray. All the positive controls spotted in this subarray are also labeled for clarification. These data show that UltraMAB anti-MUC1 (Clone UMAB57) very specifically recognizes MUC1 antigen on OriGene protein microarray chip. | UM800008CF |
| 313 | UM800017 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD2 (RC206612, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD2 (1:500). |  | Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD2 monoclonal antibody (Clone UMAB86) | UM800017CF |
| 314 | UM800017 | HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD2 (RC206612, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-CD2 (1:500). | | Western Blot analysis of extracts (35ug) from 10 different cell lines by using anti-CD2 monoclonal antibody (Clone UMAB86) | UM870017 |
| 315 | UM800115 | Flow cytometric analysis of living 293T cells transfected with PDL2 overexpression plasmid (RC224141, Red)/empty vector (PS100001, Blue) using anti-PDL2 antibody (UM800115). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). |  | HEK293T cells transfected with either RC224141 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PDCD1LG2 antibody (UM800115), and then analyzed by flow cytometry (1:100). | UM870115 |
| 316 | UM800115 | Flow cytometric analysis of living 293T cells transfected with PDL2 overexpression plasmid (RC224141, Red)/empty vector (PS100001, Blue) using anti-PDL2 antibody (UM800115). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100). | | HEK293T cells transfected with either RC224141 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-PDCD1LG2 antibody (UM800115), and then analyzed by flow cytometry (1:100). | UM800115CF |